chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I turned 65 years old in May of 2020 so this is my second high-does influenza shot.  The first shot in 2020 was a trivalent and in 2021, I received the quadrivalent.  The  influenza shot has alway affected my joints but the high-dose is significantly worse.  In 2020 the shot gave me arthritis which had taken 6 weeks until my joint returned to normal.   I am now over 7 weeks since my 2021 shot and I am still having problems with my joints.   This is significant because I need to exercise to stay healthy. Typical exercises are walking, pushups and calisthenic exercises.  I should also mention that I had my second COVID-19 Moderna shot on 02/09/2021 (if that an issue)
HCP reporting an improperly stored vaccine was administered to a patient.; No additional AE.; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported.  On 15-SEP-2022, the patient was vaccinated with improperly stored measles, mumps, rubella and varicella (oka-merck) virus vaccine live recombinant human albumin (rHA) (PROQUAD) subcutaneous injection, for prophylaxis (anatomical location and route of administration were not provided), lot # W019623 has been verified to be a valid lot number for measles, mumps, rubella and varicella (oka-merck) virus vaccine live recombinant human albumin (rHA) (PROQUAD), expiration date upon internal validation established as 19-DEC-2023 (the same as reported)(product storage error). Administrated vaccine measles, mumps, rubella and varicella (oka-merck) virus vaccine live recombinant human albumin (rHA) (PROQUAD) was stored at -11.8 Celsius degrees for 1 hour and 45 minutes, no previous temperature excursion were reported.  There were no adverse events reported (no adverse events).
Patient stood up after receiving vaccinations, stated he felt weak and tripped. Caught by father, guided back to examination chair. Patient reported feeling nauseated and was visibly diaphoretic. RN called for assistance, instructed patient to lie down on his side. Emergency kit brought to patient. Cool compress given. Patient did not lose consciousness at anytime. One episode of emesis. Reported not eating breakfast or drinking anything prior to coming into clinic. Rested for 10 minutes in exam room, stated improvement in symptoms. Able to stand and walk out with no assistance needed.
Patient states soreness and pain radiating down his arm that started a few hours after vaccination.  Visually the patient's arm looks swollen with slight redness.
rash on my injected arm; joint pains; fever; This spontaneous case was reported by an other and describes the occurrence of PYREXIA (fever), INJECTION SITE RASH (rash on my injected arm) and ARTHRALGIA (joint pains) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PYREXIA (fever), INJECTION SITE RASH (rash on my injected arm) and ARTHRALGIA (joint pains). At the time of the report, PYREXIA (fever) had resolved, INJECTION SITE RASH (rash on my injected arm) outcome was unknown and ARTHRALGIA (joint pains) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Pyrexia: 101.7.         Action taken with mRNA-1273 in response to the event was not applicable.  No concomitant drugs and treatment drugs were reported.
I saw a doctor on four different occasions. On Wednesday the 13th I had a telehealth for extreme lethargy. I couldn't get out of bed. I had the classic symptoms right after the vaccine that started late Friday night, and through Sunday. Monday the aching went away but I still couldn't get out of bed, and I was kind of lightheaded and Tuesday and Wednesday were the same. The doctor said to give it another couple of days. I made an appointment on the Saturday after that 16th and was seen by a doctor that day. She thought I had an extreme allergic reaction to the vaccine. On the following Monday, I still wasn't feeling great. I had a weird feeling in my chest, and some shortness of breath. I went to an Urgent Care, and they did, and EKG and it was abnormal. They sent me to ER Hospital. They sent me home after saying things were normal. But they weren't normal. They did not send me home with any treatment. They told me it was important that I follow up with my primary care physician. I followed up with the doctor in person on the 23rd. She is making referrals to cardiology and pulmonology. Plus, she has ordered a repeat Chest CT. No treatment yet. I still have shortness of breath, and I have an odd feeling in my chest. I have gotten some energy back. Got the flu vaccine on 9/29/2021 through my work before this 3rd dose of my COVID-19 vaccine.
HYPOTENSION 7/31/2022 CHRONIC THROMBOSIS OF INFERIOR VENA CAVA  HYPOTENSION 7/31/2022 CHRONIC THROMBOSIS OF INFERIOR VENA CAVA  HYPOTENSION 7/31/2022 POSTHEPATITIC CIRRHOSIS  HYPOTENSION 7/31/2022 CHRONIC THROMBOSIS OF INFERIOR VENA CAVA
Tested positive for the COVID Delta variant after being vaccinated; Tested positive for the COVID Delta variant after being vaccinated; He mentioned he is not feeling well.; This is a spontaneous report from a contactable consumer. This consumer reported for unknown male patient. A male patient of an unspecified age received bnt162b2 (COVID-19 VACCINE - manufacturer unknown; Solution for injection, Lot number: unknown, Expiry date: unknown), via an unspecified route of administration on an unspecified date as dose number unknown, single for COVID-19 immunization. No medical and concomitant medication history were reported. The patient experienced tested positive for the COVID delta variant after being vaccinated and not feeling well. Reporter was unsure of which vaccine was administered (only info is that it was a 2-dose version, so Moderna or Pfizer). There were no adverse reactions, only actively symptomatic. The patient underwent lab tests and procedures which included SARS-CoV-2 test positive on an unspecified date. The outcome of the events were unknown.  Information about lot/batch number cannot be obtained. Information on the lot/batch number has been requested.
Since March 1, every day I have felt dizziness and some nausea throughout the day, when I get up out of bed in the morning,  bend down and come up when doing laundry, cleaning, kitchen work, dressing, exercise and other normal daily activities.  I must keep my upper body and head upright, and avoid bending,  in order to prevent this dizziness.  As a result, I feel weak and uncomfortable, and fear doing normal movement and activity.
On 8/23/02 while playing pt stopped moving when mom picked her up her body went limp. Taken via ambulance to hospital. On 8/27/02 limp episode reoccurred x 1 min. 9/19/02 woke from nap with fever body became limp x 1 1/2 min. Per mom had seizure episode with jerking of body.
Moderna vaccine was inadvertently administered past the 30 use by date.  No sign or symptoms reported at this time.
Noticed several welts on right leg -- opposite leg that child was vaccinated on.  They were red and raised approx. the size of the end of a pencil eraser.  No fever, no vomiting or diarrhea.  Seemed happy and affable.  No treatment.  However, 24 hours later on 11/7/10  -- by 5pm -- child was covered in pinpoint pink rash on back, front torso, and arms and legs.  Still no other symptoms, but rash persisted.
like blurry vision and then she lost her senses/loss of consciousness (fainting)/passed out; like blurry vision and then she lost her senses/loss of consciousness (fainting); tachycardia; mental confusion; loss of sphincter control (urinary incontinence)/pissed on herself; diarrhea; This is a spontaneous report from a contactable consumer (patient). A 42-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration administered on arm left on 15Mar2021 13:15 (Batch/Lot number was not reported) as SINGLE DOSE for COVID-19 immunization at the pharmacy. Medical history was not reported. There were no concomitant medications. The patient was not pregnant (including at the time of vaccination). On 16Mar2021 13:15, she came around to feeling really something bad in her body. She described this as she had loss of consciousness (fainting) which started to feel like blurry vision and then she lost her senses. She then passed out for 5-8 minutes and she had loss of sphincter control (urinary incontinence) as she pissed on herself. She also had tachycardia and mental confusion by that time. They called an ambulance and she was brought to the emergency or urgency department/room. The events [loss of consciousness (fainting), loss of sphincter control (urinary incontinence), tachycardia and mental confusion] were considered as serious (medically significant). She also had several diarrhea (noted in 2021) episodes during one week. She had no COVID prior vaccination and not tested post vaccination. She would like to know if the reaction that she had with first dose vaccination was normal as she was afraid of the second one. The patient did not receive any treatment for the events of loss of consciousness (fainting), loss of sphincter control (urinary incontinence), tachycardia and mental confusion. Outcome of the event of diarrhea was unknown while recovering for the remaining events.   Information on the lot/ batch number has been requested.
Severe muscle spasms, severe headache, severe muscle pain, couldn't move,  needed assistance to walk, nausea, vomitting, slight fever (100.3) , extreme fatigue. Lasted 24 hours. Almost called ambulance.
This case was reported by a physician and described the occurrence of wrong drug administered in a 61-year-old female subject who was vaccinated with Flulaval (GlaxoSmithKline) for prophylaxis.  The subject's medical history included atrial fibrillation.  Concurrent medical conditions included allergy to dye and hypertension.  Previous and/or concurrent vaccination included influenza virus vaccine; manufacturer unspecified; left arm given on 14 November 2007.  Concurrent medications included Coumadin, Crestor, Altace, digoxin, Synthroid, Nexium and Periostat.  On 14 December 2007 at 08:30 the subject received unspecified dose of Flulaval (.5 unknown, left arm) and experienced wrong vaccine administered.  The subject was supposed to receive a pneumonia vaccine and inadvertently was given Flulaval.  A follow-up call from the consumer was received later on 14 December 2007.  She reported that she inadvertently received a second influenza vaccine (Flulaval) instead of her pneumonia vaccine.  Additional information was provided by the subject and this information has not been medically confirmed by a physician or healthcare professional.  The subject reported at an unspecified time on the same day as vaccination in her left arm with Flulaval, she reported that her left arm felt hot.  Approximately three hours after vaccination with Flulaval, the subject reported that she feels like she is about to have an episode of atrial fibrillation.  She clarified the statement and noted that she feels "heart flutters like she has had before previous episodes of atrial fibrillation."  The consumer also reported that she received influenza virus vaccine (unknown manufacturer) on 14 November 2007.  At an unspecified time after vaccination she experienced in the left arm where the vaccine was injected, a sensation of her arm feeling hot which later resolved on an unspecified date.  At the time of reporting the consumer reported that the sense of heat occurrence in the left arm had improved and the feeling of heart flutters was unresolved.
so sick for almost a month; Initial information was received on 01-Dec-2020 regarding an unsolicited valid non-serious case from a consumer or non-health care professional (patient) via social media.  This case involves patient (age and gender unspecified) who had so sick (illness), while patient received INFLUENZA VACCINE.  Medical history, medical treatment, vaccination, family history and concomitant medication were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer) [lot number, expiry date and other dosing details were not reported] for prophylactic vaccination.  On an unknown date, the patient had so sick (illness) (unknown latency) following the administration of INFLUENZA VACCINE. Event was assessed as non-serious.   Case Summary: Author/Reporter:  Product Name: Product name was not provided. Since this is a public post on the Sanofi Site we are assuming the consumer is referring to the Sanofi flu vaccine.   Details of laboratory data not reported.  It was not reported if the patient received any corrective treatment.  At the time of reporting, the event outcome was not reported for event.  There will be no information available on the batch number for this case.
A report has been received from a Pharmacist concerning a 13 year old, female subject, who had been receiving FLUMIST. FLUMIST started on 11-Nov-2013. The patient experienced administration of only a half dose of FLUMIST in one nostril which started on 11-Nov-2013. The outcome of the event of administration of only a half dose of FLUMIST in one nostril is unknown. The report was considered to be non-serious.
Severe chronic shortness of breath upon exertion, ongoing for over 4.5 months.
sixth nerve palsy of the right eye; A spontaneous report was received from a healthcare professional concerning a 73-year-old female patient, who received Moderna's COVID-19 Vaccine (mRNA-1273) and developed sixth nerve palsy of the right eye.    The patient's medical history was not provided. Concomitant product use was not provided.  On an unknown date, approximately two weeks prior to the onset of the event, the patient received their first of two planned doses of mRNA-1273 for prophylaxis of COVID-19 infection.   On 01 FEB 2021, she was seen at an ophthalmologist office and diagnosed with sixth nerve palsy of the right eye. An MRI was performed on an unknown date for the patient's condition which revealed there was mild generalized cerebral atrophy, prominent enlargement of the lateral and 3rd ventricles out of proportion to degree of cerebral atrophy. 4th ventricle is non dilated. There is patchy bilateral cerebral white matter flares. Hyperintensity is noted likely representing findings of chronic microvascular ischemic change. No obstructive lesion identified. No contiguous band of flare/T2 hyperintensity along the surface of the ventricles to suggest the presence of transependymal CSF flow. Impression was that in the setting of potential 6th nerve palsy, this constellation of findings may potentially represent underlying increased intracranial pressure. Normal pressure hydrocephalus was an alternative consideration in the appropriate clinical context. No treatment information was provided.   Action taken with second dose of mRNA-1273 in response to the event was not reported.   The outcome of the event, developed sixth nerve palsy of the right eye, was not reported.; Reporter's Comments: This case concerns a 73 year old, female patient who experienced a serious event of Ophthalmoplegia after receiving second dose of mRNA-1273 (Lot# unknown). Very limited information regarding this event has been provided at this time.  Further information has been requested.
APPROXIMATELY ONE MINUTE AFTER RECEIVING MODERNA, PT REPORTED FEELING DIZZY AND HOT.  I APPLIED ICE PACK TO WRISTS AND A COOL CLOTH TO  BACK OF PTS NECK.  PT SAID HE COULD HEAR HIS HEART BEAT LOUDLY IN HIS EARS SO  I THEN CHECKED PTS BLOOD PRESSURE , PULSE OX, AND PULSE RATE.  PTS BLOOD PRESSURE WAS SLIGHTLY ELEVATED BUT PULSE OX AND PULSE RATE WERE NORMAL.  APPROXIMATELY 5-10 MINUTES LATER, I RECHECKED PTS BLOOD PRESSURE AND IT NORMAL.  PT  ASKED FOR AND DRANK A BOTTLE OF COLD WATER.  AFTER 35 MINUTES PT SAID HE WAS FEELING BACK TO NORMAL.
had poison oak cont for 3 wks prior to MMR; kept going back into woods; seen @ clinic 1 wk p/MMR; rash on face started day p/MMR; scaly, dry crusty rash around mouth; chest pruritic;
Pt experienced severe vomiting and diarrhea, body aches, and chills.
MODERNA BIVALENT GIVEN, INSTEAD OF MONOVALENT FOR FIRST DOSE.  PATIENT INSTRUCTED TO RETURN FOR FIRST MONOVALENT VACCINE IN 8 WEEKS, THEN RETURN FOR SECOND MONOVALENT VACCINE FOUR WEEKS LATER, PER CDC GUIDELINES.
Dizziness; Nausea; This is a spontaneous report from a contactable consumer. A 13-Year-old female patient received Pfizer Covid 19 (BNT162B2) (Batch/Lot number: Not provided, Expiration date: Not provided), on 12Jun2021 around 3.30pm on left Arm as Dose 1 single for covid 19 immunization (age at vaccination: 13-Year-old). The patient had not received any other vaccine and other medication in two weeks. The patient had not affected with covid19 before or after vaccination. Medical history and Concomitant medications were not reported. On 24Jun2021 patient experienced Dizziness and nausea. No known Allergies were reported. No therapeutic treatments were received. The outcome of the events was reported as Not recovered.  Information about lot/batch number has been requested.
Excessive headache and fatigue for 2 months and counting every single day! constant all day throbbing headache on left side chest pains non stop weight gain - 15 lbs since the shot did not have any problems at all before the shot! i have not sought any medical treatment
Pain at injection site with mild erythema, fullness & warmth starting 24 hrs after injection with increased redness after 12 hrs diagnosed as local reaction - advised Benadryl, Zyrtec & ibuprofen for symptom relief with monitoring
This case was reported by a pharmacist via call center representative an described the occurrence of fever blister in a 78-year-old female patient who received SHINGRIX (batch number 3Z53C, expiry date 13th March 2021) for prophylaxis. On 28th November 2018, the patient received the 2nd dose of SHINGRIX (intramuscular). On an unknown date, less than a week after receiving SHINGRIX, the patient experienced fever blister. On an unknown date, the outcome of the fever blister was unknown.  It was unknown if the reporter considered the fever blister to be related to SHINGRIX. Additional details were provided as follows: In 2018, the patient developed fever blisters on face and mouth following administration of SHINGRIX. On the date of reporting, the patient notified pharmacy of the fever blisters. The reporter gave consent to follow up.
Chills, fatigue, severe body aches especially shoulder blade and up spine for 24 hours.  Enlarged lymph node in neck on side where injection was. That lasted 3 days. Sore to touch.
high fever of 102-103 up & down for 24 hrs; severe local react on upper thigh; refused to walk for a day;
The patient had a red rash that went from her arms to legs. She had difficulty breathing. The patient as admitted to the ER. Currently the patient is experiencing chills and headaches.
Called and left message for patient, unaware currently if there are any signs or symptoms. Found error of duplicated vaccine by doing weekly inventory of vaccines.
her blood pressure increased; She felt like her skin in the neck was burned; This is a spontaneous report from a Pfizer sponsored program.  A contactable  consumer (patient) reported for herself.  A female patient of an unspecified age  received the first dose of  bnt162b2 (BNT162B2) vaccine , via an unspecified route of administration on an unspecified date at single dose  for Covid-19 immunisation .  The patient medical history  and concomitant medications were not reported.  The patient experienced  blood pressure increased  on an unspecified date with outcome of unknown , she felt like her skin in the neck was burned  on an unspecified date with outcome of unknown.  The patient underwent lab tests and procedures which included blood pressure measurement: increased.  Information about lot/batch number has been requested.
Patient received 1st dose of Moderna COVID vaccine on 5/7/2021 and was accidentally given Pfizer Covid vaccine for 2nd dose. Patient was filling well after receiving the shot and was informed about the incidence.
Redness more than 1-2 inches around the injection site on the arm; This is a spontaneous report from a contactable physician (pediatrician) via a Pfizer sales representative. This physician reported similar event for 4 patients. This is the third of 4 reports.  A 16-year-old patient of an unspecified gender received first dose of meningococcal group b rlp2086 (TRUMENBA, lot number and expiration date were not reported), via an unspecified route of administration on an unspecified date on the patient's arm at single dose for routine vaccination.  The patient medical history and concomitant medications were not reported.  It was reported on an unspecified date that the patient experienced redness more than 1-2 inches around the injection site on the arm. The outcome of the event was recovered on an unspecified date.   Information on the batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2019291868 Same reporter/drug/event, different patient.
Patient developed tingling sensation in throat while at home, 1 hour after receiving vaccination. She went to the emergency room and was treated for trouble breathing and swelling.
Patient called around 8:30 pm 10/22/19 stating that she believed the pharmacist injected too  high on her arm. Stated she believed it went into the joint. Says unable to lift arm. Informed patient would contact PCP and let management know of claim
I got completely sick; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A male patient received bnt162b2 omi xbb.1.5 (BNT162B2 OMI XBB.1.5), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ILLNESS (non-serious), outcome "unknown", described as "I got completely sick".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Information has been received from a physician concerning a 6 year old female patient who either 2003 or 2004 was vaccinated with the first dose of VARIVAX. In April 2007, the patient was vaccinated with the second dose of VARIVAX. Several days ago, the patient had developed a rash on the back of one leg. The reporter stated that "this is not a reportable adverse event and this could possibly be caused by flea bites". The patient sought medical attention at the office. At the time of reporting the patient was recovering. No further information is available.
Patient states every time she receives a flu injection she becomes ill - apparently received injection on 12/16/2015. Seen in acute care on 12/18/2015 for increased cough congestion along with pharyngitis, body aches and low-grade fever. Exam showed throat erythema with cobblestone appearance. Because of appearance, she was treated with amoxil. She was subsequently seen in the ER on 12/21 for flu like symptoms, discharged to home.